M. Et and M. , 59 I. Objectif principal, p.60

P. Le-taux-de, T était indiqué pour 46 des CaP La valeur moyenne était de 15,34% (±10,11) et une médiane de 13-35) Il était inférieur à 15% pour 25 CAP

B. 1. Ferlay and J. , Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, vol.13, issue.5, pp.359-386, 2015.
DOI : 10.1002/ijc.29210

D. Angelis and R. , Cancer survival in Europe 1999???2007 by country and age: results of EUROCARE-5???a population-based study, The Lancet Oncology, vol.15, issue.1, pp.23-34, 2014.
DOI : 10.1016/S1470-2045(13)70546-1

A. Jemal, Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.82, issue.19 suppl, pp.69-90, 2011.
DOI : 10.3322/caac.20107

S. A. Bigler, C. R. Pound, and X. Zhou, A Retrospective Study on Pathologic Features and Racial Disparities in Prostate Cancer, Prostate Cancer, vol.98, issue.4, p.239460, 2011.
DOI : 10.1016/j.juro.2010.01.015

C. R. Ritch, Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison, BJU International, vol.14, issue.4b, pp.186-190, 2013.
DOI : 10.1111/j.1464-410X.2012.11540.x

C. E. Desantis, Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities, CA: A Cancer Journal for Clinicians, vol.137, issue.suppl 2, 2016.
DOI : 10.3322/caac.21340

R. J. Hamilton, Race, biochemical disease recurrence, and prostate???specific antigen doubling time after radical prostatectomy, Cancer, vol.38, issue.10, pp.2202-2209, 2007.
DOI : 10.1002/cncr.23012

D. Schreiber, A. Chhabra, J. Rineer, J. Weedon, and D. Schwartz, A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease?, Clinical Genitourinary Cancer, vol.13, issue.4, pp.259-264, 2015.
DOI : 10.1016/j.clgc.2015.02.006

J. S. Kang, S. J. Maygarden, J. L. Mohler, and R. S. Pruthi, Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer, BJU International, vol.33, issue.9, pp.1207-1210, 2004.
DOI : 10.1002/(SICI)1097-0142(20000301)88:5<1122::AID-CNCR24>3.3.CO;2-H

R. M. Hoffman, Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study, JNCI Journal of the National Cancer Institute, vol.93, issue.5, pp.388-395, 2001.
DOI : 10.1093/jnci/93.5.388

R. F. Sanchez-ortiz, African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men, Cancer, vol.64, issue.1, pp.75-82, 2006.
DOI : 10.1002/cncr.21954

M. Maruthappu, I. Barnes, S. Sayeed, and R. Ali, Incidence of prostate and urological cancers in England by ethnic group, 2001-2007: a descriptive study, BMC Cancer, vol.12, issue.7, p.753, 2001.
DOI : 10.1158/1055-9965.EPI-12-0965

V. Ravery, Prostate Cancer Characteristics in a Multiracial Community, European Urology, vol.53, issue.3, pp.533-538, 2008.
DOI : 10.1016/j.eururo.2007.04.048

/. Antilles-guyane and . Tous-les-numéros, Bulletin de veille sanitaire / Publications et outils / Accueil Available at: http://www.invs.sante.fr/fr/Publications-et-outils/Bulletin-de-veillesanitaire/Tous-les-numeros/Antilles-Guyane/Bulletin-de-veille-sanitaire-Antilles-Guyane

. Octobre-novembre-17, M. Dieye, J. Veronique-baudin, C. Draganescu, and H. Azaloux, Cancer incidence in Martinique: a model of epidemiological transition, Eur. J. Cancer Prev, vol.16, pp.95-101, 2007.

D. Belpomme, P. Irigaray, M. Ossondo, D. Vacque, and M. Martin, Prostate cancer as an environmental disease: An ecological study in the French Caribbean islands, Martinique and Guadeloupe, International Journal of Oncology, vol.34, issue.4, pp.1037-1044, 2009.
DOI : 10.3892/ijo_00000229

S. Hussein, S. Satturwar, and T. Van-der-kwast, Young-age prostate cancer, Journal of Clinical Pathology, vol.66, issue.7
DOI : 10.1136/jclinpath-2015-202993

M. F. Leitzmann and S. Rohrmann, Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates, Clinical Epidemiology, vol.4, pp.1-11, 2012.
DOI : 10.2147/CLEP.S16747

I. J. Powell, Epidemiology and pathophysiology of prostate cancer in

T. R. Rebbeck, Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent, Prostate Cancer, vol.379, issue.9824, p.560857, 2013.
DOI : 10.1023/A:1008966225984

A. W. Hsing, High Prevalence of Screen Detected Prostate Cancer in West Africans: Implications for Racial Disparity of Prostate Cancer, The Journal of Urology, vol.192, issue.3, pp.730-735, 2014.
DOI : 10.1016/j.juro.2014.04.017

J. Cuzick, Prevention and early detection of prostate cancer Cancer among Asian Indians/Pakistanis living in the United States: low incidence and generally above average survival, Lancet Oncol. Cancer Causes Control, vol.15, issue.20, pp.484-492, 2009.

K. Hemminki, D. P. Ankerst, J. Sundquist, and S. M. Mousavi, Prostate cancer incidence and survival in immigrants to Sweden, World Journal of Urology, vol.118, issue.5, pp.1483-1488, 2012.
DOI : 10.1007/s00345-012-1021-z

A. S. Whittemore, Prostate Cancer in Relation to Diet, Physical Activity, and Body Size in Blacks, Whites, and Asians in the United States and Canada, JNCI Journal of the National Cancer Institute, vol.87, issue.9, pp.652-661, 1995.
DOI : 10.1093/jnci/87.9.652

Y. Nakai, Review by urological pathologists improves the accuracy of Gleason grading by general pathologists 30. Nakayama, M. et al. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection, BMC Urol Am. J. Pathol, vol.15, issue.163, pp.923-933, 2003.

T. Golabek, Obesity and Prostate Cancer Incidence and Mortality: A Systematic Review of Prospective Cohort Studies, Urologia Internationalis, vol.92, issue.1, pp.7-14, 2014.
DOI : 10.1159/000351325

G. E. Sonnenberg, G. R. Krakower, and A. H. Kissebah, A Novel Pathway to the Manifestations of Metabolic Syndrome, Obesity Research, vol.107, issue.Suppl 3, pp.180-186, 2004.
DOI : 10.1038/oby.2004.24

K. Zu and E. Giovannucci, Smoking and aggressive prostate cancer: a review of the epidemiologic evidence, Cancer Causes & Control, vol.301, issue.10, pp.1799-1810, 2009.
DOI : 10.1007/s10552-009-9387-y

A. Discacciati and A. Wolk, Lifestyle and dietary factors in prostate cancer prevention. Recent Results Cancer Res, pp.27-37, 2014.

D. Belpomme, The multitude and diversity of environmental carcinogens, Environmental Research, vol.105, issue.3
DOI : 10.1016/j.envres.2007.07.002

URL : https://hal.archives-ouvertes.fr/inserm-00180815

J. M. Ritchie, Organochlorines and Risk of Prostate Cancer, Journal of Occupational and Environmental Medicine, vol.45, issue.7
DOI : 10.1097/01.jom.0000071510.96740.0b

M. C. Alavanja, Use of Agricultural Pesticides and Prostate Cancer Risk in the Agricultural Health Study Cohort, American Journal of Epidemiology, vol.157, issue.9, pp.800-814, 2003.
DOI : 10.1093/aje/kwg040

L. Multigner, P. Kadhel, F. Rouget, P. Blanchet, and S. Cordier, Chlordecone exposure and adverse effects in French West Indies populations, Environmental Science and Pollution Research, vol.3, issue.6, pp.3-8, 2016.
DOI : 10.1007/s11356-015-4621-5

URL : https://hal.archives-ouvertes.fr/hal-01150382

M. Dieye, Geographic variations and temporal trends in prostate cancer in Martinique over a 25-year period, BMC Research Notes, vol.7, issue.1, p.262, 2014.
DOI : 10.1200/JCO.2009.27.2153

URL : https://hal.archives-ouvertes.fr/inserm-00988476

G. L. Andriole, Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up, JNCI Journal of the National Cancer Institute, vol.104, issue.2
DOI : 10.1093/jnci/djr500

F. H. Schröder, Prostate-Cancer Mortality at 11 Years of Follow-up, New England Journal of Medicine, vol.366, issue.11
DOI : 10.1056/NEJMoa1113135

M. Popiolek, Natural History of Early, Localized Prostate Cancer: A Final Report from Three Decades of Follow-up, European Urology, vol.63, issue.3, pp.428-435, 2013.
DOI : 10.1016/j.eururo.2012.10.002

I. M. Thompson, Long-Term Survival of Participants in the Prostate Cancer Prevention Trial, New England Journal of Medicine, vol.369, issue.7, pp.603-610, 2004.
DOI : 10.1056/NEJMoa1215932

M. J. Roobol, A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer 48. van Vugt, H. A. et al. Prediction of prostate cancer in unscreened men: external validation of a risk calculator, Eur. Urol. Eur. J. Cancer, vol.57, issue.47, pp.79-85, 2010.

A. J. Vickers, C. Savage, M. F. O-'brien, and H. Lilja, Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer, Journal of Clinical Oncology, vol.27, issue.3, pp.398-403, 2009.
DOI : 10.1200/JCO.2008.18.1685

M. Ohi, K. Ito, K. Suzuki, T. Yamamoto, and H. Yamanaka, Diagnostic Significance of PSA Density Adjusted by Transition Zone Volume in Males with PSA Levels between 2 and 4ng/ml, European Urology, vol.45, issue.1, pp.92-96, 2004.
DOI : 10.1016/j.eururo.2003.07.001

M. Ferro, Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers, Clinica Chimica Acta, vol.413, issue.15-16, pp.1274-1278, 2012.
DOI : 10.1016/j.cca.2012.04.017

S. Loeb and W. J. Catalona, The Prostate Health Index: a new test for the detection of prostate cancer, Therapeutic Advances in Urology, vol.6, issue.2, pp.74-77, 2014.
DOI : 10.1177/1756287213513488

N. Fossati, Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study, European Urology, vol.68, issue.1, pp.132-138, 2015.
DOI : 10.1016/j.eururo.2014.07.034

S. Hori, J. Blanchet, and J. Mcloughlin, From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer, BJU International, vol.3, issue.6, pp.717-728, 2013.
DOI : 10.1111/j.1464-410X.2012.11329.x

E. Rud, E. Baco, and H. B. Eggesbø, MRI and ultrasound-guided prostate biopsy using soft image fusion, Anticancer Res, vol.32, pp.3383-3389, 2012.

J. I. Epstein, W. C. Allsbrook, M. B. Amin, L. L. Egevad, . Isup-grading et al., The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma, The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma, pp.1228-1242, 2005.
DOI : 10.1097/01.pas.0000173646.99337.b1

J. I. Epstein, Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System, International Society of Urological Pathology Am. J. Surg. Pathol, vol.40, pp.244-252, 2014.

J. I. Epstein, Gleason Score 2???4 Adenocarcinoma of the Prostate on Needle Biopsy, The American Journal of Surgical Pathology, vol.24, issue.4, pp.477-478, 2000.
DOI : 10.1097/00000478-200004000-00001

P. Zareba, J. Zhang, A. Yilmaz, and K. Trpkov, The impact of the 2005 International Society of Urological Pathology (ISUP) consensus on Gleason grading in contemporary practice, Histopathology, vol.312, issue.Suppl. 1, pp.384-391, 2009.
DOI : 10.1111/j.1365-2559.2009.03405.x

D. Danneman, L. Drevin, D. Robinson, P. Stattin, and L. Egevad, Gleason inflation 1998-2011: a registry study of 97???168 men, BJU International, vol.62, issue.2, pp.248-255, 2015.
DOI : 10.1111/bju.12671

G. M. Kunz and J. Epstein, Should each core with prostate cancer be assigned a separate gleason score?, Human Pathology, vol.34, issue.9, pp.911-914, 2003.
DOI : 10.1016/S0046-8177(03)00338-1

V. Molinié, Value of the antibody cocktail anti p63 + anti p504s for the diagnosis of prostatic cancer] Improved quality of patient care through routine second review of histopathology specimens prior to multidisciplinary meetings, Ann Pathol J. Clin. Pathol, vol.24, issue.65, pp.6-1610, 2004.

M. R. Cooperberg, D. P. Lubeck, M. V. Meng, S. S. Mehta, and P. R. Carroll, The Changing Face of Low-Risk Prostate Cancer: Trends in Clinical Presentation and Primary Management, Journal of Clinical Oncology, vol.22, issue.11, pp.2141-2149, 2004.
DOI : 10.1200/JCO.2004.10.062

A. B. Jani, Changing face and different countenances of prostate cancer:Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era, International Journal of Cancer, vol.281, issue.6, pp.363-371, 2001.
DOI : 10.1002/ijc.1035

G. Ploussard, The Contemporary Concept of Significant Versus Insignificant Prostate Cancer, European Urology, vol.60, issue.2, pp.291-303, 2011.
DOI : 10.1016/j.eururo.2011.05.006

O. Ukimura, Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care, European Urology, vol.63, issue.2, pp.214-230, 2012.
DOI : 10.1016/j.eururo.2012.09.033

D. V. Makarov, Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Gleason Score (Partin Tables) Based on Cases from 2000 to 2005, Urology, vol.69, issue.6, pp.1095-1101, 2000.
DOI : 10.1016/j.urology.2007.03.042

M. Peyromaure, P. Pro, C. R. King, J. C. Presti, J. D. Brooks et al., Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy, Prog. Urol. Int. J. Radiat. Oncol. Biol. Phys, vol.14, issue.70, pp.8-11, 2004.

C. Becker, T. Piironen, K. Pettersson, J. Hugosson, and H. Lilja, Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater, Urology, vol.55, issue.5, pp.694-699, 2000.
DOI : 10.1016/S0090-4295(99)00585-3

A. Haese, Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml, The Prostate, vol.55, issue.4, pp.101-109, 2001.
DOI : 10.1002/pros.1123

A. Gupta, Predictive Value of the Differential Expression of the Urokinase Plasminogen Activation Axis in Radical Prostatectomy Patients, European Urology, vol.55, issue.5, pp.1124-1133, 2009.
DOI : 10.1016/j.eururo.2008.06.054

R. S. Svatek, Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence, The Prostate, vol.6, issue.2, pp.886-894, 2009.
DOI : 10.1002/pros.20938

L. M. Johnson, B. Turkbey, W. D. Figg, and P. L. Choyke, Multiparametric MRI in prostate cancer management, Nature Reviews Clinical Oncology, vol.203, issue.6, pp.346-353, 2014.
DOI : 10.1016/j.crad.2007.05.022

L. Wang, Prostate Cancer: Incremental Value of Endorectal MR Imaging Findings for Prediction of Extracapsular Extension, Radiology, vol.232, issue.1, pp.133-139, 2004.
DOI : 10.1148/radiol.2321031086

P. M. Pierorazio, Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy, BJU International, vol.299, issue.8, pp.1122-1128, 2012.
DOI : 10.1111/j.1464-410X.2012.10986.x

D. V. Makarov, Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Gleason Score (Partin Tables) Based on Cases from 2000 to 2005, Urology, vol.69, issue.6, pp.1095-1101, 2000.
DOI : 10.1016/j.urology.2007.03.042

D. Elia and C. , Upgrading and upstaging in prostate cancer: From prostate biopsy to radical prostatectomy, Mol Clin Oncol, vol.2, pp.1145-1149, 2014.

I. J. Powell, C. H. Bock, J. J. Ruterbusch, and W. Sakr, Evidence Supports a Faster Growth Rate and/or Earlier Transformation to Clinically Significant Prostate Cancer in Black Than in White American Men, and Influences Racial Progression and Mortality Disparity, The Journal of Urology, vol.183, issue.5, pp.1792-1796, 2010.
DOI : 10.1016/j.juro.2010.01.015

C. Magi-galluzzi, International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease, Modern Pathology, vol.75, issue.1, pp.26-38, 2011.
DOI : 10.1046/j.1365-2559.2000.00797.x

D. I. Quinn, Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy, Cancer, vol.97, issue.8, pp.1884-1893, 2003.
DOI : 10.1002/cncr.11263

J. O. Delancey, Evidence of Perineural Invasion on Prostate Biopsy Specimen and Survival After Radical Prostatectomy, Urology, vol.81, issue.2, pp.354-357, 2006.
DOI : 10.1016/j.urology.2012.09.034

D. Danneman, F. Wiklund, N. P. Wiklund, and L. Egevad, Prognostic significance of histopathological features of extraprostatic extension of prostate cancer, Histopathology, vol.88, pp.580-589, 2013.
DOI : 10.1111/his.12199

M. Hubanks and J. , The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes, Urologic Oncology: Seminars and Original Investigations, vol.32, issue.1, pp.1-7, 2014.
DOI : 10.1016/j.urolonc.2012.09.002

B. C. Jeong, The Relationship Between the Extent of Extraprostatic Extension and Survival Following Radical Prostatectomy, European Urology, vol.67, issue.2, pp.342-346, 2015.
DOI : 10.1016/j.eururo.2014.06.015

J. I. Epstein and M. Herawi, Prostate Needle Biopsies Containing Prostatic Intraepithelial Neoplasia or Atypical Foci Suspicious for Carcinoma: Implications for Patient Care, The Journal of Urology, vol.175, issue.3, pp.820-834, 2006.
DOI : 10.1016/S0022-5347(05)00337-X

B. D. Robinson and J. Epstein, Intraductal Carcinoma of the Prostate Without Invasive Carcinoma on Needle Biopsy: Emphasis on Radical Prostatectomy Findings, The Journal of Urology, vol.184, issue.4, pp.1328-1333, 2010.
DOI : 10.1016/j.juro.2010.06.017

T. A. Wallace, Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men, Cancer Research, vol.68, issue.3, pp.927-936, 2008.
DOI : 10.1158/0008-5472.CAN-07-2608

J. Lapointe, Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis, Cancer Research, vol.67, issue.18, pp.8504-8510, 2007.
DOI : 10.1158/0008-5472.CAN-07-0673

B. S. Taylor, Integrative Genomic Profiling of Human Prostate Cancer, Cancer Cell, vol.18, issue.1, pp.11-22, 2010.
DOI : 10.1016/j.ccr.2010.05.026

R. A. Eeles, Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array, Nature Genetics, vol.38, issue.4, pp.385-391, 2013.
DOI : 10.1093/bioinformatics/btm108

I. J. Powell, Genes associated with prostate cancer are differentially expressed in

K. C. Cary and M. R. Cooperberg, Biomarkers in prostate cancer surveillance and screening: past, present, and future, Therapeutic Advances in Urology, vol.358, issue.2, pp.318-329, 2013.
DOI : 10.1001/jama.294.1.66

M. R. Cooperberg, Combined Value of Validated Clinical and Genomic Risk Stratification Tools for Predicting Prostate Cancer Mortality in a High-risk Prostatectomy Cohort, European Urology, vol.67, issue.2
DOI : 10.1016/j.eururo.2014.05.039

N. Erho, Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy, PLoS ONE, vol.18, issue.6, p.66855, 2013.
DOI : 10.1371/journal.pone.0066855.s005

T. Zellweger, Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer, International Journal of Cancer, vol.11, issue.9, pp.2116-2123, 2009.
DOI : 10.1002/ijc.24174

J. Rubio, Immunohistochemical Expression of Ki-67 Antigen, Cox-2 and Bax/Bcl-2 in Prostate Cancer; Prognostic Value in Biopsies and Radical Prostatectomy Specimens, European Urology, vol.48, issue.5
DOI : 10.1016/j.eururo.2005.06.014

G. Fisher, Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort, British Journal of Cancer, vol.8, issue.2, pp.271-277, 2013.
DOI : 10.1002/ijc.24174

H. S. Kim, Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men, Prostate Cancer and Prostatic Diseases, vol.62, issue.3, pp.262-265, 2011.
DOI : 10.1002/cncr.23012

J. Bertram, Inhibition of the Phosphatidylinositol 3'-Kinase Pathway Promotes Autocrine Fas-Induced Death of Phosphatase and Tensin Homologue-Deficient Prostate Cancer Cells, Cancer Research, vol.66, issue.9, pp.4781-4788, 2006.
DOI : 10.1158/0008-5472.CAN-05-3173

S. A. Tomlins, Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer, Science, vol.310, issue.5748, pp.644-648, 2005.
DOI : 10.1126/science.1117679

R. Esgueva, Prevalence of TMPRSS2???ERG and SLC45A3???ERG gene fusions in a large prostatectomy cohort, Modern Pathology, vol.62, issue.4, pp.539-546, 2010.
DOI : 10.1016/j.juro.2006.03.094

A. Chaux, Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas, The American Journal of Surgical Pathology, vol.35, issue.7, pp.1014-1020, 2011.
DOI : 10.1097/PAS.0b013e31821e8761

N. Cerveira, TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas, Paired HGPIN Lesions, Neoplasia, vol.8, issue.10, pp.826-832, 2006.
DOI : 10.1593/neo.06427

S. S. Salami, Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer, Urologic Oncology: Seminars and Original Investigations, vol.31, issue.5, pp.566-571, 2013.
DOI : 10.1016/j.urolonc.2011.04.001

D. K. Price, Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial, Cancer, vol.4, issue.15, pp.2332-2340, 2016.
DOI : 10.1002/cncr.30071

T. Ueda, N. R. Mawji, N. Bruchovsky, and M. D. Sadar, Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer Cells, Journal of Biological Chemistry, vol.277, issue.41, pp.38087-38094, 2002.
DOI : 10.1074/jbc.M203313200

V. Michalaki, K. Syrigos, P. Charles, and J. Waxman, Serum levels of IL-6 and TNFalpha correlate with clinicopathological features and patient survival in patients with prostate cancer, Br. J. Cancer, vol.90, pp.2312-2316, 2004.

S. F. Shariat, Association of Pre- and Postoperative Plasma Levels of Transforming Growth Factor ??1 and Interleukin 6 and Its Soluble Receptor with Prostate Cancer Progression, Clinical Cancer Research, vol.10, issue.6, pp.1992-1999, 2004.
DOI : 10.1158/1078-0432.CCR-0768-03

M. H. Johnson, SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort, The Journal of Urology, vol.196, issue.5
DOI : 10.1016/j.juro.2016.05.092

F. A. Faisal, Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location, European Urology, vol.70, issue.1, pp.14-17, 2016.
DOI : 10.1016/j.eururo.2015.09.031

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826623

K. Huang, L. R. Bégin, N. Palanisamy, B. Donnelly, and T. A. Bismar, SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development, Urologic Oncology: Seminars and Original Investigations, vol.34, issue.5, pp.1-235, 2016.
DOI : 10.1016/j.urolonc.2015.11.015

D. Bangsi, Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men???, Urologic Oncology: Seminars and Original Investigations, vol.24, issue.1, pp.21-27, 2006.
DOI : 10.1016/j.urolonc.2005.09.005

D. Bangsi, Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men???, Urologic Oncology: Seminars and Original Investigations, vol.24, issue.1, pp.21-27, 2006.
DOI : 10.1016/j.urolonc.2005.09.005

A. Olama and A. A. , Multiple loci on 8q24 associated with prostate cancer susceptibility, Nature Genetics, vol.41, issue.10, pp.1058-1060, 2009.
DOI : 10.1038/ng.452

S. Hooker, Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans, The Prostate, vol.69, issue.7, pp.270-275, 2010.
DOI : 10.1002/pros.21061

M. N. Okobia, J. M. Zmuda, R. E. Ferrell, A. L. Patrick, and C. H. Bunker, Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry, The Prostate, vol.39, issue.5, pp.1054-1063, 2011.
DOI : 10.1002/pros.21320

G. Cancel-tassin, Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe
URL : https://hal.archives-ouvertes.fr/hal-01118552

C. D. Cropp, 8q24 risk alleles and prostate cancer in African-Barbadian men, The Prostate, vol.109, issue.16, pp.1579-1588, 2014.
DOI : 10.1002/pros.22871

I. Cheng, 8q24 and prostate cancer: association with advanced disease and meta-analysis, European Journal of Human Genetics, vol.16, issue.4, pp.496-505, 2008.
DOI : 10.1158/1055-9965.EPI-06-0429

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819154

G. Cancel-tassin, Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe
URL : https://hal.archives-ouvertes.fr/hal-01118552

M. Bul, Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study, European Urology, vol.63, issue.4, pp.597-603, 2013.
DOI : 10.1016/j.eururo.2012.11.005

D. Amico and A. V. , Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer, JAMA, vol.280, issue.11, pp.969-974, 1998.
DOI : 10.1001/jama.280.11.969

M. R. Cooperberg, J. F. Hilton, and P. Carroll, The CAPRA-S score, Cancer, vol.60, issue.3 suppl 1, pp.5039-5046, 2011.
DOI : 10.1002/cncr.26169

N. Guidelines-for-patients®-|-prostate and . Cancer, Available at: https://www.nccn.org/patients/guidelines/prostate, p.44, 2016.

K. Boehm, Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models, European Urology, vol.69, issue.6, pp.1038-1043, 2016.
DOI : 10.1016/j.eururo.2015.07.051

P. A. Humphrey, H. Moch, A. L. Cubilla, T. M. Ulbright, and V. E. Reuter, The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs???Part B: Prostate and Bladder Tumours, European Urology, vol.70, issue.1, pp.106-119, 2016.
DOI : 10.1016/j.eururo.2016.02.028

J. I. Epstein, A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score, European Urology, vol.69, issue.3, pp.428-435, 2016.
DOI : 10.1016/j.eururo.2015.06.046

H. M. Ross, Do Adenocarcinomas of the Prostate With Gleason Score (GS)???6 Have the Potential to Metastasize to Lymph Nodes?, The American Journal of Surgical Pathology, vol.36, issue.9, pp.1346-1352, 2012.
DOI : 10.1097/PAS.0b013e3182556dcd

V. J. Gnanapragasam, Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study, PLOS Medicine, vol.113, issue.8, p.1002063, 2016.
DOI : 10.1371/journal.pmed.1002063.s008

H. S. Kim, Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men, Prostate Cancer and Prostatic Diseases, vol.62, issue.3, pp.262-265, 2011.
DOI : 10.1002/cncr.23012

V. L. Shavers, Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer, Journal of General Internal Medicine, vol.40, issue.2, pp.146-155, 2004.
DOI : 10.1111/j.1525-1497.2004.30209.x

M. Schmid, Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer, JAMA Oncology, vol.2, issue.1, pp.85-93, 2016.
DOI : 10.1001/jamaoncol.2015.3384

B. A. Mahal, Racial Disparities in Prostate Cancer???Specific Mortality in Men With Low-Risk Prostate Cancer, Clinical Genitourinary Cancer, vol.12, issue.5, pp.189-195, 2014.
DOI : 10.1016/j.clgc.2014.04.003

U. Mahmood, Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United States, The Journal of Urology, vol.192, issue.6, pp.1650-1656, 2014.
DOI : 10.1016/j.juro.2014.06.017

S. J. Freedland, Clinical characteristics in black and white men with prostate cancer in an equal access medical center, Urology, vol.55, issue.3, pp.387-390, 2000.
DOI : 10.1016/S0090-4295(99)00461-6

B. S. Carver, RACE IS NOT A PREDICTOR OF PROSTATE CANCER DETECTION ON REPEAT PROSTATE BIOPSY, The Journal of Urology, vol.172, issue.5, pp.1853-1855, 2004.
DOI : 10.1097/01.ju.0000141248.28904.fd

K. Swords, E. M. Wallen, and R. S. Pruthi, The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach, Urologic Oncology: Seminars and Original Investigations, vol.28, issue.3, pp.280-284, 2010.
DOI : 10.1016/j.urolonc.2008.09.021

R. Kvåle, Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study, BJU International, vol.99, issue.12, pp.1647-1654, 2009.
DOI : 10.1111/j.1464-410X.2008.08255.x

H. Janbaziroudsari, A. Mirzaei, and N. Maleki, Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy, Bulletin du Cancer, vol.103, issue.9, 2016.
DOI : 10.1016/j.bulcan.2016.05.006

I. Hosein, R. Sukhraj, L. Goetz, N. Rambarran, and S. Persaud, A Clinicopathological Profile of Prostate Cancer in Trinidad and Tobago, Advances in Urology, vol.115, issue.2, p.2075021, 2016.
DOI : 10.1093/ije/dym219

Y. Ben-shlomo, The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort Study, European Urology, vol.53, issue.1, pp.99-105, 2008.
DOI : 10.1016/j.eururo.2007.02.047

F. Chinegwundoh, Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-east London, BJU International, vol.2, issue.6, pp.1216-1220, 2006.
DOI : 10.1054/bjoc.1999.0986

F. E. Glover, THE EPIDEMIOLOGY OF PROSTATE CANCER IN JAMAICA, The Journal of Urology, vol.159, issue.6, pp.1984-1986, 1998.
DOI : 10.1016/S0022-5347(01)63220-8

C. H. Bunker, Prostate cancer screening parameters in a high-risk African-Caribbean population, Urology, vol.63, issue.4, pp.737-741, 2004.
DOI : 10.1016/j.urology.2003.10.064

S. E. Shirley, C. T. Escoffery, L. A. Sargeant, and T. Tulloch, Clinicopathological features of prostate cancer in Jamaican men, BJU International, vol.24, issue.4, pp.390-395, 2002.
DOI : 10.1046/j.1464-4096.2001.01871.x

T. R. Rebbeck, Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent, Prostate Cancer, vol.379, issue.9824, p.560857, 2013.
DOI : 10.1023/A:1008966225984

D. P. Ankerst, Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group, World Journal of Urology, vol.59, issue.2, pp.181-187, 2012.
DOI : 10.1007/s00345-011-0818-5

S. Saidi, Does prostate specific antigen density correlates with aggressiveness of the prostate cancer?, Hippokratia, vol.13, pp.232-236, 2009.

A. W. Roddam, Use of Prostate-Specific Antigen (PSA) Isoforms for the Detection of Prostate Cancer in Men with a PSA Level of 2???10 ng/ml: Systematic Review and Meta-Analysis, European Urology, vol.48, issue.3, pp.386-399, 2005.
DOI : 10.1016/j.eururo.2005.04.015

R. M. Hoffman, Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study, JNCI Journal of the National Cancer Institute, vol.93, issue.5, pp.388-395, 2001.
DOI : 10.1093/jnci/93.5.388

J. Melia, A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies, Histopathology, vol.127, issue.6, pp.644-654, 2006.
DOI : 10.1016/j.clon.2005.06.011

B. M. Mian, Role of prostate biopsy schemes in accurate prediction of Gleason scores, Urology, vol.67, issue.2, pp.379-383, 2006.
DOI : 10.1016/j.urology.2005.08.018

J. I. Epstein, Z. Feng, B. J. Trock, and P. M. Pierorazio, Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades, European Urology, vol.61, issue.5, pp.1019-1024, 2012.
DOI : 10.1016/j.eururo.2012.01.050

J. Huang, Percentage of Positive Biopsy Cores: A Better Risk Stratification Model for Prostate Cancer?, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.4, pp.1141-1148, 2012.
DOI : 10.1016/j.ijrobp.2011.09.043

R. F. Sanchez-ortiz, African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men, Cancer, vol.64, issue.1, pp.75-82, 2006.
DOI : 10.1002/cncr.21954

D. Schreiber, A. Chhabra, J. Rineer, J. Weedon, and D. Schwartz, A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease?, Clinical Genitourinary Cancer, vol.13, issue.4, pp.259-264, 2015.
DOI : 10.1016/j.clgc.2015.02.006

S. Loeb, J. I. Epstein, E. B. Humphreys, and P. C. Walsh, Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes?, BJU International, vol.70, issue.11, pp.1510-1513, 2010.
DOI : 10.1111/j.1464-410X.2009.08845.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353268

J. O. Delancey, Evidence of Perineural Invasion on Prostate Biopsy Specimen and Survival After Radical Prostatectomy, Urology, vol.81, issue.2, pp.354-357, 2013.
DOI : 10.1016/j.urology.2012.09.034

W. A. Sakr, D. J. Grignon, and G. P. Haas, Pathology of premalignant lesions and carcinoma of the prostate in African-American men, Semin. Urol. Oncol, vol.16, pp.214-220, 1998.

M. R. Cooperberg, J. M. Broering, and P. Carroll, Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer, Journal of Clinical Oncology, vol.28, issue.7, pp.1117-1123, 2010.
DOI : 10.1200/JCO.2009.26.0133

J. J. Tosoian, Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience, Journal of Clinical Oncology, vol.29, issue.16, pp.2185-2190, 2011.
DOI : 10.1200/JCO.2010.32.8112

A. Loiselle, Int??r??t de la densit?? du PSA comme facteur pr??dictif chez les patients afro-carib??ens ??ligibles ?? la surveillance active du cancer de prostate selon les crit??res du protocole fran??ais, Progr??s en Urologie, vol.24, issue.6, pp.327-333, 2014.
DOI : 10.1016/j.purol.2013.10.015

D. Sundi, African American Men With Very Low???Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?, Journal of Clinical Oncology, vol.31, issue.24, pp.2991-2997, 2013.
DOI : 10.1200/JCO.2012.47.0302

M. B. Amin, The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation, Archives of Pathology & Laboratory Medicine, vol.138, issue.10, pp.1387-1405, 2014.
DOI : 10.5858/arpa.2014-0219-SA

J. L. Silberstein, Active Surveillance of Prostate Cancer in African American Men, Urology, vol.84, issue.6, pp.1255-1261, 2014.
DOI : 10.1016/j.urology.2014.06.064

R. A. Smith, C. J. Mettlin, K. J. Davis, and H. Eyre, American Cancer Society guidelines for the early detection of cancer, CA: A Cancer Journal for Clinicians, vol.50, issue.1, pp.34-49, 2000.
DOI : 10.3322/canjclin.50.1.34

D. Shenoy, S. Packianathan, A. M. Chen, and S. Vijayakumar, Do African-American men need separate prostate cancer screening guidelines?, BMC Urology, vol.27, issue.8, p.19, 2016.
DOI : 10.1186/s12894-016-0137-7

URL : http://doi.org/10.1186/s12894-016-0137-7

N. Mottet and . Mottet-eau-guidelines-recherche-google, Available at: https://uroweb, Prostate-Cancer_LR.pdf, p.26, 2016.